Glenmark launches COVID-19 drug in India

Published: Jun 20, 2020, 10:25 PM(IST)
Glenmark announced the launch of the first oral Favipiravir claiming that it is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19.
Read in App